NASDAQ:SYRA - Nasdaq - US87168W2035 - Common Stock - Currency: USD
0.1043
-0.02 (-17.94%)
The current stock price of SYRA is 0.1043 USD. In the past month the price decreased by -67.85%. In the past year, price decreased by -89.87%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 12.07 | 89.50B | ||
CVS | CVS HEALTH CORP | 12.42 | 84.95B | ||
DGX | QUEST DIAGNOSTICS INC | 18.16 | 18.28B | ||
LH | LABCORP HOLDINGS INC | 14.9 | 18.17B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 12.78 | 13.88B | ||
DVA | DAVITA INC | 14.74 | 11.20B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 110.15 | 10.60B | ||
CHE | CHEMED CORP | 25.14 | 8.50B | ||
HIMS | HIMS & HERS HEALTH INC | 50.43 | 6.05B | ||
CRVL | CORVEL CORP | 27.53 | 5.91B | ||
GH | GUARDANT HEALTH INC | N/A | 5.55B | ||
OPCH | OPTION CARE HEALTH INC | 26.25 | 5.26B |
Syra Health Corp. operates as a medical technology company, which engages in developing end-to-end solutions in health education services, population health management, behavioral and mental health, healthcare workforce and digital health. The company is headquartered in Carmel, Indiana. The company went IPO on 2023-09-29. The firm provides comprehensive end-to-end solutions in behavioral and mental health, population health, digital health, health education and healthcare workforce. The Company’s health education service line offers services, including medical communications, patient education, and healthcare training. Its population health management services include analytics as a service, epidemiology and health equity analytics solutions. The Company’s digital health solutions include digital transformation, cloud and security, artificial intelligence, patient engagement, and health applications. Its Syrenity is a comprehensive mental health application that provides preventative care and interventions for behavioral and mental health. The company provides medical education solutions to pharmaceutical and medical device manufacturers, biotechnology companies, payers, large employers, academic institutions, and government agencies.
SYRA HEALTH CORP - CLASS A
1119 Keystone Way N., #201
Carmel INDIANA US
Employees: 120
Company Website: https://www.syrahealth.com/
Investor Relations: http://ir.syrahealth.com/
Phone: 14633458950
The current stock price of SYRA is 0.1043 USD. The price decreased by -17.94% in the last trading session.
The exchange symbol of SYRA HEALTH CORP - CLASS A is SYRA and it is listed on the Nasdaq exchange.
SYRA stock is listed on the Nasdaq exchange.
null analysts have analysed SYRA and the average price target is 1.84 USD. This implies a price increase of 1660.31% is expected in the next year compared to the current price of 0.1043. Check the SYRA HEALTH CORP - CLASS A stock analysts ratings, price target forecast and up-and down grades for more detailed information.
SYRA HEALTH CORP - CLASS A (SYRA) has a market capitalization of 1.18M USD. This makes SYRA a Nano Cap stock.
SYRA HEALTH CORP - CLASS A (SYRA) currently has 120 employees.
SYRA HEALTH CORP - CLASS A (SYRA) has a resistance level at 0.19. Check the full technical report for a detailed analysis of SYRA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SYRA does not pay a dividend.
SYRA HEALTH CORP - CLASS A (SYRA) will report earnings on 2025-05-07.
SYRA HEALTH CORP - CLASS A (SYRA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.54).
The outstanding short interest for SYRA HEALTH CORP - CLASS A (SYRA) is 11.7% of its float. Check the ownership tab for more information on the SYRA short interest.
ChartMill assigns a fundamental rating of 2 / 10 to SYRA. While SYRA seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months SYRA reported a non-GAAP Earnings per Share(EPS) of -0.54. The EPS decreased by -8.98% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -102.17% | ||
ROE | -130.59% | ||
Debt/Equity | 0.05 |